Please note that the ANZCTR website will be unavailable from 3pm until 3.15pm (AEST) on Tuesday 20th February for website maintenance. Please be sure to log out of the system in order to avoid any loss of data. Thank you and apologies for any inconvenience caused.

Trial registered on ANZCTR


Trial ID
ACTRN12605000228684
Ethics application status
Approved
Date submitted
25/08/2005
Date registered
26/08/2005
Date last updated
26/08/2005
Type of registration
Retrospectively registered

Titles & IDs
Public title
BAL fluid mitogenic activity as a predictor of lung function and radiologic decline in asbestos exposed workers.
Scientific title
BAL fluid mitogenic activity as a predictor of lung function and radiologic decline in asbestos exposed workers.
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Asbestosis 314 0
Condition category
Condition code
Inflammatory and Immune System 358 358 0 0
Other inflammatory or immune system disorders

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Nil
Intervention code [1] 257 0
None
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 415 0
Lung function
Timepoint [1] 415 0
Primary outcome [2] 416 0
Cardiopulmonary Excercise Test performance
Timepoint [2] 416 0
Primary outcome [3] 417 0
Radiologic abnormalities
Timepoint [3] 417 0
Secondary outcome [1] 889 0
Cardiopulmonary Excercise Test performance
Timepoint [1] 889 0
Secondary outcome [2] 890 0
Radiologic abnormalities
Timepoint [2] 890 0

Eligibility
Key inclusion criteria
Occupational asbestos exposure
Minimum age
Not stated
Maximum age
Not stated
Gender
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
No exclusion criteria

Study design
Purpose
Natural history
Duration
Longitudinal
Selection
Convenience sample
Timing
Prospective
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 417 0
Name [1] 417 0
Address [1] 417 0
Country [1] 417 0
Primary sponsor type
Individual
Name
Fergal Oâ¿¿Donoghue
Address
Country
Secondary sponsor category [1] 337 0
Individual
Name [1] 337 0
Bill Musk
Address [1] 337 0
Country [1] 337 0

Ethics approval
Ethics application status
Approved

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 35958 0
Address 35958 0
Country 35958 0
Phone 35958 0
Fax 35958 0
Email 35958 0
Contact person for public queries
Name 9446 0
Fergal O'Donoghue
Address 9446 0
Institute for Breathing and Sleep
Department of Respiratory and Sleep Medicine
Austin Health
Heidelberg VIC 3084
Country 9446 0
Australia
Phone 9446 0
+61 3 94963688
Fax 9446 0
+61 3 94965124
Email 9446 0
Fergal.O'Donoghue@austin.org.au
Contact person for scientific queries
Name 374 0
Fergal O'Donoghue
Address 374 0
Institute for Breathing and Sleep
Department of Respiratory and Sleep Medicine
Austin Health
Heidelberg VIC 3084
Country 374 0
Australia
Phone 374 0
+61 3 94963688
Fax 374 0
+61 3 94965124
Email 374 0
Fergal.O'Donoghue@austin.org.au